Aspex Management (HK)’s Synopsys SNPS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.39B Buy
3,112,646
+442,114
+17% +$208M 15.62% 1
2026
Q1
$1.06B Buy
2,670,532
+544,443
+26% +$246M 15.35% 1
2025
Q4
$999M Buy
2,126,089
+608,507
+40% +$270M 20.2% 1
2025
Q3
$749M Buy
1,517,582
+871,687
+135% +$493M 15.85% 2
2025
Q2
$331M Buy
645,895
+332,364
+106% +$155M 7.2% 5
2025
Q1
$134M Buy
+313,531
New +$152M 3.46% 12

Other funds holding SNPS

Aspex Management (HK)'s SNPS Position: Q2 2026 in Review

Aspex Management (HK) increased its Synopsys (SNPS) stake by 17% in Q2 2026, buying an estimated $208M and bringing the position to 3,112,646 shares worth $1.39B. The position accounts for 15.62% of the portfolio, ranked #1.

Aspex Management (HK) first reported a position in SNPS in Q1 2025 and has held it in 6 quarters since. 1,444 funds tracked by Wall St. Rank hold SNPS as of Q2 2026.

  • Aspex Management (HK) held 3,112,646 shares of Synopsys worth $1.39B as of Q2 2026.
  • Aspex Management (HK) bought 442,114 Synopsys shares in Q2 2026, an estimated $208M.
  • Synopsys made up 15.62% of Aspex Management (HK)'s portfolio in Q2 2026, its #1 holding.
  • Aspex Management (HK) first reported a position in Synopsys in Q1 2025 and has held it in 6 quarters since.
  • 1,444 funds tracked by Wall St. Rank held Synopsys as of Q2 2026.

Based on Aspex Management (HK)'s 13F filing for Q2 2026, filed 14 Aug 2026.